Episode 43: Spoilt for choice - the many treatments now available for AMD and DME

from Talking Euretina · host Whipsmart Media

Following the approval of Aflibercept 8mg, clinicians in Europe now have 5 anti-VEGF treatments to choose from, not to mention biosimilars. How should we treat patients with so many options open to us? Sandrine Zweifel (Switzerland) and Stela Vujosevic (Italy) compare notes

Episode metadata supplied by the publisher feed · Published Jan 31, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

Episode 43: Spoilt for choice - the many treatments now available for AMD and DME

0:00 22:08

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Talking Euretina?

This episode is 22 minutes long.

When was this Talking Euretina episode published?

This episode was published on January 31, 2024.

Can I download this Talking Euretina episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!